Intellectual property

News

Appeals court turns Enhertu patent dispute on its head

A US appeals court has reversed a 2023 decision that ordered Daiichi Sankyo to pay royalties on sales of cancer drug Enhertu to Seagen (now Pfizer).

News

Eisai says patent win blocks Lenvima generic to 2036

Eisai has won a lawsuit blocking FDA approval of Shilpa's generic of cancer blockbuster Lenvima until 2036, although the verdict could go to appeal.

News

Indian Commerce Minister Piyush Goyal and Business and Trade Secretary Jonathan Reynolds

UK trumpets a trade deal with India - but pharma isn't happy

Various industries have welcomed news of a trade deal between the UK and India, but Britain's pharma sector isn't among them.

News

US District Court for the Western District of Washington at Seattle

AbbVie sues Genmab, claiming trade secrets theft

A multibillion-dollar partnership between AbbVie and Genmab risks being soured by a lawsuit claiming misappropriation of trade secrets.

News

Insulin pump firm Insulet wins $452m in trade secrets clash

Insulet is celebrating a jury's verdict that rival South Korean firm EOFlow stole trade secrets relating to its wearable insulin pump technology.

Digital

AI as an inventor: Defining ownership in the pharma sector

The global pharmaceutical industry is witnessing a surge in innovation, with the industry experiencing a 5% growth in the number of AI-related patent applications in Q1 2024 and

Appeals court turns Enhertu patent dispute on its head

Eisai says patent win blocks Lenvima generic to 2036

UK trumpets a trade deal with India - but pharma isn't happy

AbbVie sues Genmab, claiming trade secrets theft

Insulin pump firm Insulet wins $452m in trade secrets clash

AI as an inventor: Defining ownership in the pharma sector

OpenBind unveils its first AI model for drug discovery

Discover a new era of healthcare panel engagement: Grounded ...

Intellectual property

Editor's Picks